Search results
Insmed shares target raised by H.C. Wainwright on positive trial data By Investing.com
Investing.com· 13 hours agoThe ASPEN trial results showed a reduction in annualized rates of pulmonary exacerbations (PEs) for...
Republican CD1 candidates talk gun control, foreign affairs and immigration in radio debate
Maine Morning Star via Yahoo News· 4 hours agoTwo Republicans from southern Maine will face off in the upcoming June 11 primary election for the...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 1 day agoThe mean reduction was 13.90 in the placebo group, 15.61 in the 10 mg group and 16.94 in the 20 mg group. A clear dose response and a clinically meaningful, but not statistically ...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoThe double-blind randomised study involved a total of 1,174 patients. Participants were assigned in...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 2 days agoAfter 24 weeks, resolution of morphologic antibody-mediated rejection occurred in nine of the 11...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 12 hours agoJ&J said its drug was “safe and well-tolerated” in the study, noting that rates of common side...
Add-On to GLP-1s Yields Greater Weight Loss
Medscape· 18 hours agoCombination therapy of bupropion/naltrexone and GLP-1 receptor agonists showed a synergistic weight loss effect in individuals with obesity who responded...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe multicentre, double-blind, placebo-controlled study enrolled 500 subjects, who were randomised...
NS Pharma reports data from Phase III Duchenne treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe randomised, placebo-controlled study enrolled 77 male patients with DMD who were able to walk....
Novartis’ atrasentan shows to reduce proteinuria in Phase III IgAN trial
Clinical Trials Arena via Yahoo Finance· 3 days agoNovartis has unveiled interim results from the Phase III ALIGN clinical trial where atrasentan...